United States · FDA National Drug Code directory
sumatriptan
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 64980-660_44569522-5e18-4e73-bb20-cac2c0f7a12f
- Product NDC
- 64980-660
- Form
- TABLET, FILM COATED
- Composition / generic term
- sumatriptan
- Labeler
- Rising Pharma Holdings, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250505
- Source listing expiry
- 20261231
Source-listed ingredients
- SUMATRIPTAN SUCCINATE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 BLISTER PACK in 1 CARTON (64980-660-27) / 9 TABLET, FILM COATED in 1 BLISTER PACK · 64980-660-27
- 36 TABLET, FILM COATED in 1 BOTTLE (64980-660-36) · 64980-660-36
- 1 BLISTER PACK in 1 CARTON (64980-660-91) / 9 TABLET, FILM COATED in 1 BLISTER PACK · 64980-660-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →